If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAfriag Global Regulatory News (AFRI)

  • There is currently no data for AFRI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

27 Jun 2014 15:47

RNS Number : 8055K
AfriAg PLC
27 June 2014
 



AfriAg Plc

 

("AfriAg" or the "Company")

 

Final results for the year ended 31 December 2013

 

Chairman's Statement

 

 

I am pleased to present the final results for the year ended 31 December 2013.

 

This has been a period of considerable change for the Group.

 

During the early part of year, the Company's name and investing policy was changed and I was appointed Executive Chairman. The Company also completed the purchase of a 40% equity interest in African agri-logistics company AfriAg Pty Ltd ("AfriAg SA") and acquired a portfolio of shares in various quoted agricultural companies in accordance with the Company's stated investing policy.

 

Following these investments being made the Company has now substantially implemented its investing policy in accordance with rule 15 of the AIM Rules for Companies.

 

The 40% investment in AfriAg SA was made in July 2013. Since then, AfriAg SA has gradually grown its fleet of AfriAg-branded special purpose refrigerated trucks that now transport perishable food and agricultural related produce around southern Africa and then transport these products to supermarkets in Europe, the Middle East and Asia by sea and air freight. Any revenue due to the Company will be by way of periodic dividends from AfriAg SA. The Company is not anticipating any dividends in the short term as any excess working capital from AfriAg SA is being retained to assist with growing that business.

 

On 17 June 2014, the Company announced its intention to establish a new wholly-owned food marketing and sales and distribution division called AfriAg Marketing, in South Africa with the prime focus of sourcing and then marketing African produce (fresh and frozen) within the southern African region as well as from southern Africa to global markets. 

 

My fellow director Donald Strang and I are in the process of being appointed as the initial directors of this new division. It is proposed that during the start-up phase of this new division that funding will be provided from the Company's current cash reserves. AfriAg Marketing is seeing multiple global opportunities to assist with sourcing and supplying African food produce; in particular in Asia and the Middle East. We will use this new wholly owned division to capitalise on these opportunities for the Company.

 

The board is confident that AfriAg Marketing will be fully operational by the end of July 2014.

 

Results for the period

 

The Group's net loss after taxation for the year was £0.31million (2012 - £4.775 million loss).

 

Current assets including cash at 31 December 2013 amounted to £244,000 (31 December 2012: £179,000). This has been subsequently boosted since year-end with the £400,000 share placement completed in June 2014.

 

Outlook

 

The current Board considers that adoption of the new Investing Policy is in the best interests of the Company and its Shareholders as a whole. The Board envisages an exciting growth period for the Company as it continues to implement its investment strategy of focusing on African related agri-business and agri-logistics and continues to evaluate new investment opportunities in these sectors as they arise.

 

Since the creation of AfriAg a year ago, the Company had only raised a net £600,000 to year end to rescue the previous business (previously 3D Resources plc, which had been scheduled for de-listing from AIM), pay out old outstanding creditors and invest in a number of agri related businesses. The recent £400,000 funding in June 2014 significantly improved the Company's balance sheet and will enable the Company to grow and continue with its stated investment policy.

 

The Board would like to take this opportunity to thank our shareholders for their continued support.

 

I look forward to reporting further progress over the next period and beyond.

 

 

David Lenigas

Executive Chairman

 

27 June 2014

 

 

 

For further information please contact:

 

 

 

AfriAg Plc

David Lenigas

Donald Strang

 

+44 (0) 20 7440 0640

 

Cairn Financial Advisers LLP

Nominated Adviser and Broker

James Caithie / Jo Turner / Carolyn Sansom

 

+44 (0) 20 7148 7900

 

Square Consulting

Public Relations

David Bick/Mark Longson

 

+44 (0) 20 7929 5599

 

 

 

Consolidated Statement of Comprehensive Income for the period to 31 December 2013

 

 

Year ended

31 December

2013

18 month period to

31 December

2012

Note

£

£

Revenue

2,000

-

Cost of sales

-

-

Gross Profit

2,000

-

Administration expenses

(310,342)

466,134

Loss of disposal of investment

-

203,292

Write off of group balance

-

4,105,158

Operating (loss)

4-5

(308,342)

(4,774,584)

Share of associate result

1,831

-

(Loss) before taxation

(306,511)

(4,774,584)

Taxation

7

-

-

(Loss) for the period attributable to equity holders of the parent

(306,511)

(4,774,584)

Other comprehensive income

Gain on revaluation of available for sale investments

9,788

-

(Loss) on revaluation of derivative financial instrument

(300,000)

-

Other comprehensive income for the period net of taxation

(290,212)

-

Total comprehensive income for the year attributable to equity holders of the parent

(596,723)

(4,774,584)

Loss per share

8

Basic and diluted

(0.03)

(0.58)

 

 

 

 

Consolidated Statement of financial position at 31 December 2013

 

 

31 December

31 December

2013

2012

Note

£

£

Non-current assets

Investments in associates

10

1,328,831

-

1,328,831

-

Current assets

Available for sale assets

11

211,077

-

Trade and other receivables

12

20,225

7,066

Derivative financial instrument

14

-

-

Cash and cash equivalents

12,426

171,925

243,728

178,991

Total assets

1,572,559

178,991

Current liabilities

Trade and other payables

13

(148,173)

(21,282)

(148,173)

(21,282)

Net current assets

95,555

157,709

Net assets

1,424,386

157,709

Equity

Share capital

15

1,055,501

820,975

Share premium account

7,963,148

6,334,274

Share based payment reserve

181,025

193,134

Revaluation reserves

(290,212)

-

Retained earnings

(7,485,076)

(7,190,674)

1,424,386

157,709

 

The financial statements of AfriAg plc (registered number 002845V) were approved by the Board of Directors and authorised for issue on 27 June 2014 and were signed on its behalf by:

 

 

 

David Lenigas

Chairman

 

 

Company Statement of financial position at 31 December 2013

 

 

31 December

31 December

2013

2012

Note

£

£

Non-current assets

Investments in subsidiary undertakings

9

11

-

Trade and other receivables

12

1,326,989

-

1,327,000

-

Current assets

Available for sale assets

11

211,077

Trade and other receivables

12

20,225

7,066

Derivative financial instrument

14

-

-

Cash and cash equivalents

12,426

171,925

243,728

178,991

Total assets

1,570,728

178,991

Current liabilities

Trade and other payables

13

(148,173)

(21,282)

(148,173)

(21,282)

Net current assets

95,555

157,709

Net assets

1,422,555

157,709

Equity

Share capital

15

1,055,501

820,975

Share premium account

7,963,148

6,334,274

Share based payment reserve

181,025

193,134

Revaluation reserves

(290,212)

-

Retained earnings

(7,486,907)

(7,190,674)

1,422,555

157,709

 

The financial statements of AfriAg plc (registered number 002845V) were approved by the Board of Directors and authorised for issue on 27 June 2014 and were signed on its behalf by:

 

 

 

David Lenigas

Chairman

 

 

Consolidated Statement of changes in equity for the period to 31 December 2013

 

 

 

Share

capital

 

Share

premium

Share based

payment

reserve

Revaluation reserves

 

Retained

earnings

 

 

Total

£

£

£

£

£

£

At 30 June 2011

170,475

5,366,966

68,220

-

(2,623,593)

2,982,068

Loss for the period

-

-

-

-

(4,774,584)

(4,774,584)

Total Comprehensive Income

-

-

-

-

(4,774,584)

(4,774,584)

Shares issued (net of expenses)

 

270,500

 

1,233,308

 

-

-

 

-

 

1,503,808

Subscriber shares

380,000

(266,000)

-

-

-

114,000

Share based payment expense

 

-

 

-

 

332,417

-

 

-

 

332,417

Release when options cancelled

 

-

 

-

 

(207,503)

-

 

207,503

 

-

Total contributions by and distributions to owners of the Company

650,500

967,308

124,914

-

207,503

1,950,225

At 31 December 2012

820,975

6,334,274

193,134

-

(7,190,674)

157,709

Loss for the period

-

-

-

-

(306,511)

(306,511)

Gain on revaluation of available for sale investments

-

-

-

9,788

-

9,788

(Loss) on revaluation of derivative financial instrument

-

-

-

(300,000)

-

(300,000)

Total Comprehensive Income

-

-

-

(290,212)

(306,511)

(596,723)

Shares issued (net of expenses)

234,526

1,628,874

-

-

-

1,863,400

Options and warrants exercised

-

-

(12,109)

-

12,109

-

Total contributions by and distributions to owners of the Company

234,526

1,628,874

(12,109)

-

12,109

1,863,400

At 31 December 2013

1,055,501

7,963,148

181,025

(290,212)

(7,485,076)

1,424,386

 

 

 

Company Statement of changes in equity for the period to 31 December 2013

 

 

 

Share

capital

 

Share

premium

Share based

payment

reserve

Revaluation reserves

 

Retained

earnings

 

 

Total

£

£

£

£

£

£

At 30 June 2011

170,475

5,366,966

68,220

-

(2,623,593)

2,982,068

Loss for the period

-

-

-

-

(4,774,584)

(4,774,584)

Total Comprehensive Income

-

-

-

-

(4,774,584)

(4,774,584)

Shares issued (net of expenses)

 

270,500

 

1,233,308

 

-

-

 

-

 

1,503,808

Subscriber shares

380,000

(266,000)

-

-

-

114,000

Share based payment expense

 

-

 

-

 

332,417

-

 

-

 

332,417

Release when options cancelled

 

-

 

-

 

(207,503)

-

 

207,503

 

-

Total contributions by and distributions to owners of the Company

650,500

967,308

124,914

-

207,503

1,950,225

At 31 December 2012

820,975

6,334,274

193,134

-

(7,190,674)

157,709

Loss for the period

-

-

-

-

(308,342)

(308,342)

Gain on revaluation of available for sale investments

-

-

-

9,788

-

9,788

(Loss) on revaluation of derivative financial instrument

-

-

-

(300,000)

-

(300,000)

Total Comprehensive Income

-

-

-

(290,212)

(308,342)

(598,554)

Shares issued (net of expenses)

234,526

1,628,874

-

-

-

1,863,400

Options and warrants exercised

-

-

(12,109)

-

12,109

-

Total contributions by and distributions to owners of the Company

234,526

1,628,874

(12,109)

-

12,109

1,863,400

At 31 December 2013

1,055,501

7,963,148

181,025

(290,212)

(7,486,907)

1,422,555

 

 

Consolidated Cash flow statement for the period ended 31 December 2013

 

 

12 month period to 31

18 month period to 31

Dec 2013

Dec 2012

£

£

Cash flows from operating activities

Operating (loss)

(308,342)

(4,774,584)

(Increase)/decrease in trade and other receivables

(13,159)

2,527,339

Increase/(decrease) in trade and other payables

126,891

(22,749)

Share option charge

-

193,134

Investment write-off

-

203,292

Net cash outflow in operating activities

(194,610)

(1,873,568)

Investing activities

Investment in assets held for sale

(201,289)

-

Investment in associate

(10,000)

-

Net cash outflow in investing activities

(211,289)

-

Financing activities

Issue of share capital

616,400

1,724,000

Issue costs

(70,000)

(106,192)

Payment for derivative financial instrument

(300,000)

-

Net cash inflow from financing activities

246,400

1,617,808

Net decrease and cash and cash equivalents

(159,499)

(255,760)

Cash and cash equivalents at beginning of period

171,925

427,685

Cash and cash equivalents at end of period

12,426

171,925

 

 

 

Company Cash flow statement for the period ended 31 December 2013

 

 

12 month period to 31

18 month period to 31

Dec 2013

Dec 2012

£

£

Cash flows from operating activities

Operating (loss)

(308,342)

(4,774,584)

(Increase)/decrease in trade and other receivables

(13,159)

2,527,339

Increase/(decrease) in trade and other payables

126,891

(22,749)

Share option charge

-

193,134

Investment write-off

-

203,292

Net cash outflow in operating activities

(194,610)

(1,873,568)

Investing activities

Investments in subsidiary undertakings

(11)

-

Investment in assets held for sale

(201,289)

-

Loans granted to subsidiaries

(9,989)

-

Net cash outflow in investing activities

(211,289)

-

Financing activities

Issue of share capital

616,400

1,724,000

Issue costs

(70,000)

(106,192)

Payment for derivative financial instrument

(300,000)

-

Net cash inflow from financing activities

246,400

1,617,808

Net decrease and cash and cash equivalents

(159,499)

(255,760)

Cash and cash equivalents at beginning of period

171,925

427,685

Cash and cash equivalents at end of period

12,426

171,925

 

 

Notes to the financial statements

 

 

1 General information

 

AfriAg plc is a company incorporated in the Isle of Man under the Isle of Man Companies Act 2006. AfriAg plc's shares are listed on the AIM of the London Stock Exchange. The Company changed its name from 3D Resources Plc by resolution on 24 April 2013.

 

These accounts have been prepared in Sterling because that is the currency of the primary economic environment in which the Company operates.

 

Adoption of new or amended IFRS

 

In the current year, the following new and revised Standards and Interpretations have been adopted and have affected the amounts reported in these financial statements.

IFRS 13 Fair Value Measurement

 

The Company has applied IFRS13 for the first time in the current year. IFRS13 establishes a single source of guidance for fair value measurements and disclosures about fair value measurements. IFRS13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction in the principal (or most advantageous) market at the measurement date under current market conditions. Fair value under IFRS13 is an exit price regardless of whether that price is directly observable or estimated using another valuation technique. Also, IFRS13 includes extensive disclosure requirements.

IFRS13 requires prospective application from 1 January 2013. In addition, specific transitional provisions were given to entities such that they need not apply the disclosure requirements set out in the Standard in comparative information provided for periods before the initial application of the Standard.

In accordance with these transitional provisions, the Company has not made any new disclosures required by IFRS13 for the 2012 comparative period. Other than the additional disclosures, the application of IFRS13 has not had any impact on the amounts recognised in the consolidated financial statements.

 

Amendments to IAS1 Presentation of Financial Statements

(as part of the Annual Improvements to IFRSs 2009; 2011 Cycle issued in May 2012)

The Annual Improvements to IFRSs 2009; 2011 have made a number of amendments to IFRSs. The amendments that are relevant to the Company are the amendments to IAS1 regarding when a statement of financial position as at the beginning of the preceding period (third statement of financial position) and the related notes are required to be presented. The amendments specify that a third statement of financial position is required when a) an entity applies an accounting policy retrospectively, or makes a retrospective restatement or reclassification of items in its financial statements, and b) the retrospective application, restatement or reclassification has a material effect on the information in the third statement of financial position. The amendments specify that related notes are not required to accompany the third statement of financial position.

This has no impact for the 2013 financial statements.

 

 

Amendments to IFRS7 Disclosures

The Company has applied the amendments to IFRS7 Disclosures-Offsetting Financial Assets and Financial Liabilities for the first time in the current year. The amendments to IFRS7 require entities to disclose information about rights of offset and related arrangements (such as collateral posting requirements) for financial instruments under an enforceable master netting agreement or similar arrangement.

As the Company does not have any offsetting arrangements in place, the application of the amendments has had no impact on the disclosures or on the amounts recognised in the financial statements.

At the date of authorisation of these financial statements, the following Standards and Interpretations which have not been applied in these financial statements were in issue but not yet effective (and in some cases had not yet been adopted by the EU):

IFRS9 Financial Instruments

IFRS10 Consolidated Financial Statements

IFRS12 Joint Arrangements#

IAS27 (revised) Investment Entities

IAS28 (revised) Investments in Associates and Joint Ventures

IAS32 (revised) Offsetting Financial Assets and Financial Liabilities

IAS36 (revised) Recoverable Amount Disclosures for Non Financial Assets

IAS39 (revised) Novation of Derivatives and Continuation of Hedge Accounting

IFRIC Interpretation21 Levies

The directors do not expect that the adoption of the Standards and Interpretations listed above will have a material impact on the financial statements of the Company in future periods, except as that IFRS9 will impact both the measurement and disclosures of Financial Instruments.

Beyond the information above, it is not practicable to provide a reasonable estimate of the effect of these standards until a detailed review has been completed.

The directors do not expect that the adoption of the standards listed above will have a material impact on the financial statements of the Company in future periods, however, it is not practicable to provide a reasonable estimate of the effect of these standards until a detailed review has been completed.

 

 

2 Significant accounting policies

 

Basis of preparation

 

The accounts have been prepared in accordance with International Financial Reporting Standards (IFRSs) adopted for the use in the European Union.

 

The accounts have been prepared under the historical cost convention. The principal accounting policies are set out below.

 

 

Basis of Consolidation

The Group financial statements consolidate those of the Company and all of its subsidiary undertakings drawn up to the balance sheet date. Subsidiaries are entities over which the Company has the power to control, directly or indirectly, the financial and operating policies so as to obtain benefits from their activities. The Company obtains and exercises control through voting rights. Subsidiaries are fully consolidated from the date at which control is transferred to the Company. They are deconsolidated from the date that control ceases.

 

Unrealised gains on transactions between the Company and its subsidiaries are eliminated. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Amounts reported in the financial statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.

 

Acquisitions of subsidiaries are dealt with by the acquisition method. The acquisition method involves the recognition at fair value of all identifiable assets and liabilities, including contingent liabilities of the subsidiary, at the acquisition date, regardless of whether or not they were recorded in the financial statements of the subsidiary prior to acquisition. On initial recognition, the assets and liabilities of the subsidiary are included in the consolidated balance sheet at their fair values, which are also used as the bases for subsequent measurement in accordance with the Group accounting policies. Goodwill is stated after separating out identifiable intangible assets. Goodwill represents the excess of acquisition cost over the fair value of the Group's share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Acquisition costs are written off as incurred.

 

Investments in associates are initially recognised at cost and subsequently accounted for using the equity method. Any goodwill or fair value adjustment attributable to the Group's share in the associate is not recognised separately and is included in the amount recognised as investment in associate. The carrying amount of the investment in associates is increased or decreased to recognise the Group's share of the profit or loss and other comprehensive income of the associate, adjusted where necessary to ensure consistency with the accounting policies of the Group. Unrealised gains and losses on transactions between the Group and its associates are eliminated to the extent of the Group's interest in those entities. Where unrealised losses are eliminated, the underlying asset is also tested for impairment

 

Going concern

 

Notwithstanding the loss incurred during the period under review, the Directors are of the opinion that ongoing evaluations of the Company's interests and cash resources, indicate that preparation of the Company's accounts on a going concern basis is appropriate.

 

Revenue recognition

 

Revenue is measured at the fair value of the consideration received or receivable and represents amounts from the sales of goods provided in the normal course of business, net of value added tax and discounts, and is recognised when the significant risks and rewards of ownership of the product have been transferred to a third party. In the case of sale or return transactions, revenue is only recognised when, and only to the level that, risks and rewards are transferred.

 

Revenue is the invoiced value of goods and services supplied and excludes VAT and other sales based taxes.

 

 

Financial instruments

 

Financial assets and financial liabilities are recognised on the Company's balance sheet when the Company becomes a party to the contractual provisions of the instrument.

 

The Company's activities give rise to some exposure to the financial risks of changes in interest rates and foreign currency exchange rates. The Company has no borrowings and is principally funded by equity, maintaining all its funds in bank accounts.

 

Financial assets

 

Financial assets are classified into the following specified categories; financial assets "at fair value through profit or loss" (FVTPL), "held to maturity" investments, "available for sale" (AFS) financial assets and "loans and receivables". The classification depends on the nature and purpose of the financial assets and is determined at the time of initial recognition.

 

Available for sale financial assets

 

Available-for-sale financial assets are non-derivative financial assets that are either designated to this category or do not qualify for inclusion in any of the other categories of financial assets. The Group's available-for-sale financial assets include listed securities. These available-for-sale financial assets are measured at fair value. Gains and losses are recognised in other comprehensive income and reported within the available-for-sale reserve within equity, except for impairment losses and foreign exchange differences, which are recognised in profit or loss. When the asset is disposed of or is determined to be impaired, the cumulative gain or loss recognised in other comprehensive income is reclassified from the equity reserve to profit or loss and presented as a reclassification adjustment within other comprehensive income. Interest calculated using the effective interest method and dividends are recognised in profit or loss within finance income.

 

Reversals of impairment losses are recognised in other comprehensive income.

 

Equity

 

Share capital is determined using the nominal value of shares that have been issued.

 

The share premium account represents premiums received on the initial issuing of the share capital. Any transaction costs associated with the issuing of shares are deducted from share premium, net of any related income tax benefits.

 

The share based payment reserve represents the cumulative amount which has been expensed in the income statement in connection with share based payments, less any amounts transferred to retained earnings on the exercise of share options.

 

Revaluation reserve represents the unrealised gain or loss on fair/market value movement on available for sale investments and other assets which are valued at their fair value at the balance sheet date.

 

Retained earnings include all current and prior period results as disclosed in the income statement.

 

 

Cash

 

Cash includes cash in hand, deposits held at call with banks, and bank overdrafts. Bank overdrafts are shown within current liabilities on the balance sheet.

 

Financial liabilities

 

Trade payables

Trade payables are non-interest-bearing and are initially measured at fair value and thereafter at amortised cost using the effective interest rate.

 

Taxation

 

The tax expense represents the sum of the tax currently payable and deferred tax.

 

The tax currently payable is based on taxable profit for the period. Taxable profit differs from the net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other periods and it further excludes items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Provisions

 

Provisions are recognised when the Company has a present obligation as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation. The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation.

 

Share based payments

 

The Company issues equity-settled share based benefits to employees. All equity-settled share-based payments are ultimately recognised as an expense in profit or loss with a corresponding credit to reserves.

Share-based payments relating to the subsidiary company increase the carrying value of the investment in the subsidiary and are included in the loss on disposal of the subsidiary.

 

If vesting periods or other non-market vesting conditions apply, the expense is allocated over the vesting period, based on the best available estimate of the number of share options expected to vest. Estimates are subsequently revised if there is any indication that the number of share options expected to vest differs from previous estimates. Any cumulative adjustment prior to vesting is recognised in the current period. No adjustment is made to any expense recognised in prior periods if share options ultimately exercised are different to that estimated on vesting.

 

Upon exercise of share options the proceeds received net of attributable transaction costs are credited to share capital, and where appropriate share premium.

 

 

3 Critical accounting judgements and key sources of estimation uncertainty

 

In the process of applying the Company's accounting policies, as described in note 2, management has made the following judgements that have the most significant effect on the amounts recognised in the financial statements.

 

Valuation of share based payments to employees

 

The Company estimates the expected value of share based payments to employees and this is charged through the income statement over the vesting period. The fair value is estimated using the Black Scholes valuation model which requires a number of assumptions to be made such as level of share vesting, time of exercise, expected length of service and employee turnover and share price volatility. This method of estimating the value of share based payments is intended to ensure that the actual value transferred to employees is provided for by the time such payments are made.

 

4 Segmental information

 

An operating segment is a distinguishable component of the Group that engages in business activities from which it may earn revenues and incur expenses, whose operating results are regularly reviewed by the Group's chief operating decision maker to make decisions about the allocation of resources and assessment of performance and about which discrete financial information is available.

The chief operating decision maker has defined that the Group's only reportable operating segment during the period is the agriculture and logistics sector.

 

Subject to further acquisitions the Group expects to further review its segmental information during the forthcoming financial year.

 

The Group has not generated any revenues from external customers during the period, £2,000 (2012: £nil) revenue is from management fees to the associate company.

 

In respect of the total assets, £243,728 (2012: £178,991) arise in the UK, and £1,327,000 (2012: £nil) arise in South Africa.

 

 

5

Operating loss

 

Year to 31

18 month Period to 31

Dec 2013

Dec 2012

£

£

Operating loss is stated after charging:

Share options

-

193,134

Audit

10,000

5,000

Loss on disposal of investment

-

203,292

Write off of subsidiary company balance

-

4,105,158

Included in share options is £nil (2012 - £27,377) relating to directors.

In addition to auditors' remuneration shown above, the auditors received the following fees for non audit services.

2013

2012

£

£

Other financial advisory services

-

-

 

6

Directors' emoluments

Fees and benefits

135,000

65,280

The Company has no directly employed personnel.

 

Fees and

Share based

salaries

payments

Total

2013

£000

£000

£000

D Lenigas (#2)

32,000

-

32,000

D Strang

48,000

-

48,000

H Harris

48,000

-

48,000

O Cooke (#1)

7,000

7,000

135,000

-

135,000

2012

£000

£000

£000

D Strang

2,000

9,126

11,126

H Harris

2,000

9,126

11,126

O Cooke

21,760

9,125

30,885

J Noble (#3)

19,760

-

19,760

G Lay(#3)

19,760

-

19,760

65,280

27,377

92,657

 

#1 - resigned 17 May 2013.

#2 - appointed 24 April 2013.

#3 - resigned 24 October 2012.

Directors' interest in share options is set out in note 16.

 

 

7

Taxation

 

Year to 31

18 month Period to 31

Dec 2013

Dec 2012

£

£

 

Total current tax

-

-

The actual tax charges for the period differs from the standard rate applicable in the UK of 23/24% (2012 - 24/26%) for the reasons set out in the following reconciliation:

 

 

2013

2012

 

£

£

 

Loss on ordinary activities before tax

(306,511)

(4,774,584)

 

Tax thereon @ rates above

(71,264)

(1,169,773)

Factors affecting charge for the period:

Losses arising in territories where no tax is charged

(71,264)

1,169,773

Current tax charge for the period

-

-

 

8 Loss per share

 

IAS 33 "Earnings per share" requires presentation of diluted earnings / (loss) per share when a company could be called upon to issue shares that would decrease profit or increase loss per share. For a loss making company with outstanding share options, loss per share would only be increased by the exercise of out of money options. Since it seems inappropriate to assume that option holders would exercise out of money options, no adjustment has been made to calculate the diluted loss per share on out of money share options.

 

Basic and diluted loss per share are calculated on the loss of the company attributable to equity holders of the parent of £306,511 (Period ended 31 December 2012 - £4,774,584) and on weighted average number of ordinary shares of 893,299,984 (31 December 2012 - 820,974,824) in issue.

 

 

 

9

Investments in subsidiaries - Company

31 December

31 December

 

2013

2012

 

£

£

 

Cost and net book value

 

At 1 January

-

64,009

 

Capital contribution

-

139,283

 

Additions

11

-

 

Disposal

-

(203,292)

 

 

At 31 December

11

-

 

 

 

The investment was sold for a consideration of £1.

 

 

The following were subsidiary undertakings held directly by the Company at the end of the year:

Name

Country of incorporation

Proportion of voting rights and ordinary share capital held voting right

Nature of business

AfriAg Limited

England

100%

Holding Company

AfriAg Limited

BVI

100%

Dormant Company

 

 

10

Investment in associate - Group

 

31 December

31 December

2013

2012

£

£

At 1 January

-

-

Addition at cost

1,327,000

-

Share of associate result

1,831

-

Carrying value at 31 December

1,328,831

-

 

The Group's share of results of its associate, which is unlisted, and its aggregated assets and liabilities, is as follows:

 

Name

Country of incorporation

Assets

Liabilities

Revenues

Profit/(Loss)

% interest held

 

 

As at 31 December 2013

Year to 31 December 2013

 

AfriAg (Pty) Ltd

South Africa

£20,062

£12,030

£13,124

£9,130

40

 

AfriAg (Pty) Limited's year end is 31 December.

 

 

11

Available-for-sale investments - Group & Company

 

31 December

31 December

2013

2012

Current Assets - Listed investments

£

£

At 1 January

-

-

Acquired during the period

201,289

-

Movement in market value

9,788

-

At 31 December

211,077

-

 

Available-for-sale investments comprise investments in listed securities which are traded on stock markets throughout the world, and are held by the Group as a mix of strategic and short term investments.

 

12

Trade and other receivables

31 December 2013

31 December 2012

Group

£

Company

£

Group

£

Company

£

Current trade and other receivables

Other debtors

18,225

18,225

7,066

7,066

Accrued income

2,000

2,000

-

-

Total

20,225

20,225

7,066

7,066

 

Non-Current trade and other receivables

 

Loans due from subsidiaries

-

1,326,989

-

-

Total

-

1,326,989

-

-

 

Loans outstanding and due from subsidiaries, are interest free and repayable on demand.

 

 

13

Trade and other payables

31 December 2013

31 December 2012

Group

£

Company

£

Group

£

Company

£

Current trade and other payables

Trade creditors

35,173

35,173

3,282

3,282

Accruals

113,000

113,000

18,000

18,000-

Total

148,173

148,173

21,282

21,282

 

 

 

 

14

Derivative Financial Instrument - Group & Company

 31 December 2013

31 December 2012

Shares in Group undertaking

£

£

Company

Cost

Fair value as at 1 January

-

-

Cost of equity swap arrangement

300,000

-

Fair value adjustment

(300,000)

-

As at 31 December

-

-

On 12 September 2013 the Company announced that it had entered into an equity swap agreement with YAGM over 29,126,213 of the Company's shares. In return for a payment by the Company to YAGM of £300,000 ("the Initial Escrowed Funds"), twelve monthly settlement payments were to be made by YAGM to the Company, or by the Company to YAGM, based on a formula related to the difference between the prevailing market price of the Company's ordinary shares in any month and a 'benchmark price' that is 10% above the Subscription Price. Thus the funds received by the Company in respect of the Swap Shares are dependent on the future price performance of the Company's ordinary shares.

 

The Initial Escrowed Funds was deposited into an escrow account and the subsequent monthly settlement payments will be managed through the Escrow Account under the terms of the Equity Swap Agreement.

 

YAGM may elect to terminate the Equity Swap Agreement and accelerate the payments due under it in certain circumstances. The Company may pause a monthly payment under the Equity Swap Agreement once in each six month period.

 

YAGM has agreed that it and its affiliates will refrain from holding any net short position in respect of the Company's ordinary shares and has agreed restrictions on the volume of ordinary shares in the Company that it can trade from time to time until the expiry or if earlier termination of the Equity Swap Agreement.

 

By 31 December 2013 nil shares had been closed out for net proceeds of £nil. The remaining balance has been fair valued at 31 December 2013, which has resulted in a fair value adjustment decrease based on the benchmark price and formula of the arrangement, with the unrealised loss debited to revaluation reserve and highlighted in other comprehensive income.

 

Please see note 21 for events after the reporting period relating to this note.

 

 

 

 

 

15

Share capital

2013

2012

£

£

 

Allotted, issued and fully paid

1,055,501,037 (2012 - 820,974,824) ordinary shares of £0.001 each

1,055,501

820,975

The Company has one class of ordinary shares which carries no right to fixed income.

 

On 21 August 2013, 4,400,000 shares were issued on the exercise of warrants at 0.1p per share.

 

On 6 September 2013, the Company issued 188,000,000 shares as part of the acquisition of the 40% share in AfriAg (Pty) Limited, at a price of 0.7p per share. Non-cash consideration.

 

On 12 September 2013, 29,126,213 shares were issued in a Placing and Equity Swap, at 2.06p per share.

 

On 30 October 2013, 13,000,000 shares were issued on exercise of share options at 0.1p per share.

 

During the year ended 31 December 2013, the Company issued a total of 234,526,213 ordinary shares (2012: 650,500,000 ordinary shares).

 

 

 

Warrants in issue

 

As at 1 January 2013, shareholders had the option of up to 200,000,000 subscription warrants for each subscription share, exercisable at 0.1p per ordinary share. During the year, 4,400,000 warrants were exercised (2012: nil) at 0.1p per share. No warrants were cancelled or lapsed during the period (2012: nil).

 

As at 31 December 2013, 195,600,000 warrants (2012: 200,000,000) remain outstanding.

 

 

Share Options

 

The Company has as at 31 December 2013, 69,000,000 (2012: 82,000,000) share options issued through its share schemes. During the year no options were issued (2012: 82,000,000), 13,000,000 options were exercised (2012: nil), no options were cancelled or lapsed (2012: nil).

 

 

 

 

16

Share based payments

December

2012

Options

December

2012

Warrants

Number of options

82,000,000

200,000,000

Volatility

15.76%

15.76%

Spot price

£0.00165

£0.00165

Interest rate

0.82%

0.82%

Dividend yield

Nil

Nil

Vesting period

1 year

1 year

Contractual life

8 years

3 years

Option value weighted average exercise price

£0.001

£0.001

 

The volatility assumption is based upon historic share price volatility in the medical sector.

 

Options granted to certain employees are subject to additional exercise conditions based on the satisfaction of certain performance criteria

 

As disclosed in note 5 the share option charge for the period was £nil (2012 - £193,134).

 

 

 

Exercise

Price

 

1st Anniversary

Date

 

 

Expiry

Date

 

31 December 2012

 

 

 

Granted

 

 

 

Exercised

 

 

31 December

2013

Weighted

average

exercise

 price

Summary of options

Enterprise management incentive scheme

£0.001

07/12/2012

31/12/2020

82,000,000

-

(13,000,000)

69,000,000

£0.001

82,000,000

-

(13,000,000)

69,000,000

Summary of warrants

£0.001

07/12/2012

31/12/2015

200,000,000

-

(4,400,000)

195,600,000

£0.001

 

 

 

17

Financial instruments

The Group's financial instruments comprise cash at bank and payables which arise in the normal course of business. It is, and has been throughout the period under review, the Group's policy that no speculative trading in financial instruments shall be undertaken. The Group has been solely equity funded during the period. As a result the main risk arising from the Group's financial instruments is currency risk.

 

Details of the significant accounting policies and methods adopted, including the criteria for recognition, the basis of measurement and the basis on which income and expenses are recognised, in respect of each class of financial asset, financial liability and equity instrument are disclosed in note 2 of the accounts.

 

2013

2012

 

£

£

 

Financial assets (current)

Cash and cash equivalents

12,426

171,925

 

Financial liabilities (current)

Trade payables

35,173

3,282

 

 

 

Interest rate risk and liquidity risk

The Group is funded by equity, maintaining all its funds in bank accounts. The Group's policy throughout the period has been to minimise the risk of placing available funds on short term deposit. The short term deposits are placed with banks for periods up to 1 month according to funding requirements.

 

The Group had no undrawn committed borrowing facilities at any time during the period.

 

Fair values

Cash and cash equivalents (which are presented as a single class of assets on the face of the balance sheet) comprise cash held by the company with an original maturity of three months or less. The carrying amount of these assets approximates their fair value.

 

The directors consider there to be no material difference between the book value of financial instruments and their values at the balance sheet date.

 

 

 

 

18

Related party transactions

 

Transactions between the Company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not disclosed in this note. Transactions between other related parties are discussed below.

During the period, there were no related party transactions to disclose.

Remuneration of Key Management Personnel

The remuneration of the Directors and other key management personnel of the Group are set out below in aggregate for each of the categories specified in IAS24 Related party Disclosures.

2013

2012

£

£

Short-term employee benefits

135,000

65,280

Share-based payments

-

27,377

135,000

92,657

 

19

Capital Commitments & Contingent Liabilities

 

There are no non-cancellable capital commitments as at the balance sheet date. The Group has no contingent liabilities at the balance sheet date.

 

20

Ultimate control

 

The Company has no individual controlling party.

 

21

Events after the reporting period

 

On 11 June 2014, the Company completed a placing of 100,000,000 ordinary shares at a price of 0.4p per share, raising gross proceeds of £400,000.

 

On 11 June 2014, the Company, agreed with YAGM to cancel the equity swap arrangement for £300,000 in aggregate, and the issue of 32,500,000 ordinary shares to YAGM.

 

22

Profit and loss account of the parent company

 

As permitted by the Isle of Man Companies Act 2006, the profit and loss account of the parent company has not been separately presented in these accounts. The parent company loss for the year was £308,342 (2012: £4,774,584).

 

23

Posting of accounts

 

The Report and Accounts for the year ended 31 December 2013 will be posted to shareholders on 30 June 2014 and will be available on the Company's website on the same date.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SELFLWFLSELM
Date   Source Headline
16th Feb 20165:44 pmRNSResult of GM - Proposed Delisting from AIM
25th Jan 201612:30 pmRNSProposed Cancellation on AIM and Notice of GM
21st Dec 20157:00 amRNSDirectorate Change
9th Oct 20157:00 amRNSFirst Day of Dealings on ISDX
28th Sep 20153:00 pmRNSApplication for Admission to ISDX
25th Sep 20155:38 pmRNSDirector/PDMR Shareholding
25th Sep 20157:00 amRNSDirector/PDMR Shareholding
24th Sep 20157:00 amRNSHalf Yearly Report
4th Aug 20157:00 amRNSTrading Update - Agri-Logistics business growth
24th Jul 20154:12 pmRNSResult of AGM
26th Jun 201511:16 amRNSFinal Results
5th Feb 20159:02 amRNSNew logistics contract with Gatsby (Africa)
27th Jan 20157:00 amRNSSix month update on AfriAg SA and AfriAg Marketing
4th Nov 20144:20 pmRNSPlacing
20th Oct 20147:00 amRNSAfriAg Marketing Trading Update
3rd Oct 20143:40 pmRNSEstablishment of Share Incentive Plan and EBT
30th Sep 20144:13 pmRNSUnaudited Interim Results
27th Aug 20144:40 pmRNSSecond Price Monitoring Extn
27th Aug 20144:35 pmRNSPrice Monitoring Extension
27th Aug 20147:00 amRNSAfriAg Marketing - First exports by sea to China
21st Aug 20147:00 amRNSAfriAg's Marketing Division secures initial orders
20th Aug 20147:00 amRNSAfriAg Marketing ready for business
19th Aug 20147:00 amRNS6 month trading update on airfreight operations
23rd Jul 201412:56 pmRNSResult of AGM
27th Jun 20143:47 pmRNSFinal Results
26th Jun 20144:58 pmRNSHolding(s) in Company
24th Jun 201411:39 amRNSHolding(s) in Company
18th Jun 20144:33 pmRNSHolding(s) in Company
17th Jun 20147:00 amRNSIntention to establish a new division
11th Jun 20143:47 pmRNSCancellation of YAGM Equity Swap and Placing
11th Jun 20147:00 amRNSPlacing
6th Jun 20141:33 pmRNSHolding(s) in Company
21st May 20147:00 amRNSChange of Adviser
30th Apr 20147:01 amRNSHolding in Company
15th Apr 201410:36 amRNSUpdate on Equity Swap with YAGM
4th Apr 20149:00 amRNSTrading Update
26th Mar 20144:40 pmRNSSecond Price Monitoring Extn
26th Mar 20144:35 pmRNSPrice Monitoring Extension
26th Mar 20141:09 pmRNSTrading Statement
4th Dec 201310:20 amRNSHolding in Company
30th Oct 20134:00 pmRNSExercise of Options
23rd Oct 201310:22 amRNSInvestments and Implementation of Investing Policy
7th Oct 20132:00 pmRNSAfriAg SA contract with United Exports
3rd Oct 201312:05 pmRNSHolding(s) in Company
27th Sep 20132:20 pmRNSHalf Yearly Report
26th Sep 20132:00 pmRNSHolding in Company
20th Sep 20137:00 amRNSIAG Cargo becomes carrier of choice
12th Sep 20133:06 pmRNSHolding(s) in Company
12th Sep 20137:00 amRNSPlacing and Equity Swap
6th Sep 20137:00 amRNSCompletion of investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.